Mature human induced pluripotent stem cell-derived cardiomyocytes promote angiogenesis through alpha-B crystallin

被引:4
作者
Tanaka, Yuki [1 ,3 ]
Kadota, Shin [1 ,2 ]
Zhao, Jian [1 ]
Kobayashi, Hideki [1 ,4 ]
Okano, Satomi [1 ,11 ]
Izumi, Masaki [1 ,12 ]
Honda, Yusuke [1 ]
Ichimura, Hajime [1 ,3 ]
Shiba, Naoko [1 ,5 ]
Uemura, Takeshi [2 ,6 ]
Wada, Yuko [3 ]
Chuma, Shinichiro [7 ]
Nakada, Tsutomu [8 ]
Tohyama, Shugo [9 ]
Fukuda, Keiichi [9 ]
Yamada, Mitsuhiko [10 ]
Seto, Tatsuichiro [3 ]
Kuwahara, Koichiro [2 ,4 ]
Shiba, Yuji [1 ,2 ]
机构
[1] Shinshu Univ, Sch Med, Dept Regenerat Sci & Med, 3-1-1 Asahi, Matsumoto 3908621, Japan
[2] Shinshu Univ, Inst Biomed Sci, Matsumoto 3908621, Japan
[3] Shinshu Univ, Sch Med, Dept Surg, Div Cardiovasc Surg, Matsumoto 3908621, Japan
[4] Shinshu Univ, Sch Med, Dept Cardiovasc Med, Matsumoto 3908621, Japan
[5] Shinshu Univ, Sch Med, Dept Pediat, Matsumoto 3908621, Japan
[6] Shinshu Univ, Res Ctr Adv Sci & Technol, Div Gene Res, Matsumoto 3908621, Japan
[7] Kyoto Univ, Inst Life & Med Sci, Dept Regenerat Sci & Engn, Kyoto 6068507, Japan
[8] Shinshu Univ, Res Ctr Adv Sci & Technol, Div Instrumental Anal, Matsumoto 3908621, Japan
[9] Keio Univ, Sch Med, Dept Cardiol, Tokyo 1608582, Japan
[10] Shinshu Univ, Sch Med, Dept Mol Pharmacol, Matsumoto 3908621, Japan
[11] Iryo Sosei Univ, Fac Hlth Sci, Dept Phys Therapy, Iwaki 9708551, Japan
[12] Shinshu Univ, Sch Med, Dept Internal Med, Div Diabet Endocrinol & Metab, Matsumoto 3908621, Japan
关键词
Human induced pluripotent stem cell-derived cardiomyocytes; Engraftment; Cell transplantation; Angiogenesis; Maturation; CRYAB; HEART FUNCTION; MATURATION; TRANSPLANTATION; REMUSCULARIZATION; ARRHYTHMIAS; SURVIVAL; PACKAGE; CANCER; GROWTH; READS;
D O I
10.1186/s13287-023-03468-4
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Background Human induced pluripotent stem cell- derived cardiomyocytes (hiPSC-CMs) can be used to treat heart diseases; however, the optimal maturity of hiPSC-CMs for effective regenerative medicine remains unclear. We aimed to investigate the benefits of long-term cultured mature hiPSC-CMs in injured rat hearts. Methods Cardiomyocytes were differentiated from hiPSCs via monolayer culturing, and the cells were harvested on day 28 or 56 (D28-CMs or D56-CMs, respectively) after differentiation. We transplanted D28- CMs or D56-CMs into the hearts of rat myocardial infarction models and examined cell retention and engraftment via in vivo bioluminescence imaging and histological analysis. We performed transcriptomic sequencing analysis to elucidate the genetic profiles before and after hiPSC-CM transplantation. Results Upregulated expression of mature sarcomere genes in vitro was observed in D56- CMs compared with D28CMs. In vivo bioluminescence imaging studies revealed increased bioluminescence intensity of D56-CMs at 8 and 12 weeks post-transplantation. Histological and immunohistochemical analyses showed that D56-CMs promoted engraftment and maturation in the graft area at 12 weeks post-transplantation. Notably, D56-CMs consistently promoted microvessel formation in the graft area from 1 to 12 weeks post-transplantation. Transcriptomic sequencing analysis revealed that compared with the engrafted D28-CMs, the engrafted D56-CMs enriched genes related to blood vessel regulation at 12 weeks post-transplantation. As shown by transcriptomic and western blot analyses, the expression of a small heat shock protein, alpha-B crystallin (CRYAB), was significantly upregulated in D56-CMs compared with D28-CMs. Endothelial cell migration was inhibited by small interfering RNA-mediated knockdown of CRYAB when co-cultured with D56-CMs in vitro. Furthermore, CRYAB overexpression enhanced angiogenesis in the D28- CM grafts at 4 weeks post-transplantation. Conclusions Long-term cultured mature hiPSC-CMs promoted engraftment, maturation and angiogenesis post-transplantation in infarcted rat hearts. CRYAB, which was highly expressed in D56-CMs, was identified as an angiogenic factor from mature hiPSC-CMs. This study revealed the benefits of long-term culture, which may enhance the therapeutic potential of hiPSC-CMs.
引用
收藏
页数:20
相关论文
共 50 条
  • [31] Engineered Maturation Approaches of Human Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes
    Ge, Feixiang
    Wang, Zetian
    Xi, Jianzhong Jeff
    CELLS, 2020, 9 (01)
  • [32] Perspective from the heart: The potential of human pluripotent stem cell-derived cardiomyocytes
    Xu, Xiu Qin
    Sun, William
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2013, 114 (01) : 39 - 46
  • [33] Challenges and perspectives of heart repair with pluripotent stem cell-derived cardiomyocytes
    Eschenhagen, Thomas
    Weinberger, Florian
    NATURE CARDIOVASCULAR RESEARCH, 2024, 3 (05): : 515 - 524
  • [34] Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues
    Feric, Nicole T.
    Radisic, Milica
    ADVANCED DRUG DELIVERY REVIEWS, 2016, 96 : 110 - 134
  • [35] Transplantation of Human Pluripotent Stem Cell-Derived Cardiomyocytes for Cardiac Regenerative Therapy
    Silver, Sophia E.
    Barrs, Ryan W.
    Mei, Ying
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [36] Strategies to improve the therapeutic effect of pluripotent stem cell-derived cardiomyocytes on myocardial infarction
    Xiao, Yang
    Chen, Yihuan
    Shao, Chunlai
    Wang, Yaning
    Hu, Shijun
    Lei, Wei
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2022, 10
  • [37] Maturation of pluripotent stem cell-derived cardiomyocytes: limitations and challenges from metabolic aspects
    Jiang, Xi
    Lian, Xin
    Wei, Kun
    Zhang, Jie
    Yu, Kaihua
    Li, Haoming
    Ma, Haichun
    Cai, Yin
    Pang, Lei
    STEM CELL RESEARCH & THERAPY, 2024, 15 (01)
  • [38] In Vivo Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Neonatal and Adult Rat Hearts
    Kadota, Shin
    Pabon, Lil
    Reinecke, Hans
    Murry, Charles E.
    STEM CELL REPORTS, 2017, 8 (02): : 278 - 289
  • [39] GLUT4 expression and glucose transport in human induced pluripotent stem cell-derived cardiomyocytes
    Bowman, Peter R. T.
    Smith, Godfrey L.
    Gould, Gwyn W.
    PLOS ONE, 2019, 14 (07):
  • [40] Challenges and innovation: Disease modeling using human-induced pluripotent stem cell-derived cardiomyocytes
    Reilly, Louise
    Munawar, Saba
    Zhang, Jianhua
    Crone, Wendy C. C.
    Eckhardt, Lee L. L.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9